| Pharmaceutical active ingredients: |
| Coagulation Factor VIII Human |
| Available forms, composition and doses of Monoclate-P: |
| Injectable; Injection; Coagulation Factor VIII Human 250 IUInjectable; Injection; Coagulation Factor VIII Human 500 IUInjectable; Injection; Coagulation Factor VIII Human 1000 IUInjectable; Injection; Coagulation Factor VIII Human 100 IU / mlInjectable; Injection; Coagulation Factor VIII Human 1500 IU / 10 mlInjectable; Injection; Coagulation Factor VIII Human 350 IU / 2.5 mlInjectable; Injection; Coagulation Factor VIII Human 700 IU / 5 ml |
| Monoclate-P medical category: |
| Human:Hemostatics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B02BD02 - Coagulation Factor VIII |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisGerolymatosMedibrandsRephachemZLB BehringZydus Cadila |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Haemate-P | Coagulation Factor VIII Human | CSL |
| Hemofil M | Coagulation Factor VIII Human | Baxter; Bioscience; Firma Chun Cheong; Teva; United Italian Trading |
| Koate D-IV | Coagulation Factor VIII Human | Bayer Schering Pharma |
| Koate-DVI | Coagulation Factor VIII Human | Bayer Schering Pharma; Dipa Pharmalab Intersains; Gador; GenAsia Biotech; Luen Cheong Hong; Octafarma; Talecris; Talecris Biotherapeutics; Zuellig Pharma |
| Monarc-M | Coagulation Factor VIII Human | Baxter; American Red Cross; Kamada; Teva |
| Octanate | Coagulation Factor VIII Human | Octapharma; B L Hua; Bago Laboratorios; Varifarma Laboratorio |
| Recombinate | Coagulation Factor VIII Human | Baxter; Teva |
| Wilstart | Coagulation Factor VIII Human; Von Willebrand Factor Human | LFB Biomedicaments |
| Feiba | Coagulation Factor VIII Inhibitor Bypassing Fraction | Baxter; Immuno Productos Biologicos e Quimicos; Teva |
| Feiba NF | Coagulation Factor VIII Inhibitor Bypassing Fraction | Baxter |